
By Mariam Sunny and Michael Erman
(Reuters) -Merck said on Monday it expects a commercial opportunity exceeding $5 billion from Cidara Therapeutics' experimental flu drug, and does not anticipate it to require a review by the U.S. CDC's vaccine advisory panel before launch.
The U.S. drugmaker announced a nearly $9.2 billion deal last week to acquire Cidara, aiming to gain access to its long-acting antiviral, CD388, currently in late-stage trial.
CD388 is not a vaccine and is designed to be effective regardless of a person's immune status and could offer single-dose, universal protection against all flu strains.
Vaccine policy in the United States has been undergoing a shift under Health Secretary Robert F. Kennedy Jr., a longtime vaccine skeptic, who has revamped the Centers for Disease Control and Prevention's panel of outside advisers and prompted the ouster of its director.
"I would not say that our view of what is happening around vaccinations has in any way affected either our view of vaccinations or what drove us to this (drug)," Merck CEO Robert Davis said during a call with analysts.
Merck expects about 110 million Americans to be eligible to receive CD388, including 85 million considered at high risk for influenza. It plans to manufacture the drug long-term at one of its U.S. facilities.
The company said it expects Cidara's acquisition to reduce earnings by about 30 cents per share over the first 12 months from the deal's closing, reflecting investments to advance CD388 and the assumed cost of financing.
The deal is expected to close in the first quarter of 2026.
(Reporting by Mariam Sunny in Bengaluru and Michael Erman in New Jersey; Editing by Shilpi Majumdar)
LATEST POSTS
- 1
BravoCon 2025: How to watch, full schedule and lineup, where to stream free and more - 2
As tetanus vaccination rates decline, doctors worry about rising case numbers - 3
7 Fun Plans to Make Film Evenings Seriously Energizing (You'll Cherish #5!) - 4
Minute Maid’s frozen juice concentrate is ending after 80 years — and so is a certain kind of kitchen ritual - 5
The Best 10 Innovation Developments of the Year
Monetary Versatility: Get ready for Life's Unforeseen Difficulties
Vinicultural Investigation: A Survey of \Enjoying Fine Vintages\ Wine sampling
The most effective method to Move toward Compensation Conversations for Cutting edge Practice Enrolled Attendants
Top Smoothie Flavor: What's Your Mix?
NASA chief Jared Isaacman says Texas may get a moonship, not space shuttle Discovery
Vaccine makers raise concerns over US panel's shift away from hepatitis B shots for newborns
Find the Advantages of Positive Nurturing: Supporting Cheerful and Sound Kids
James Webb Space Telescope finds strongest evidence yet for atmosphere around rocky exoplanet: 'It's really like a wet lava ball'
Foreign military officials can become Israel's ambassadors, senior IDF commander tells 'Post'













